AC Immune SA

NASDAQ:ACIU

3.11 (USD) • At close October 22, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 0.687014.8010000.0013.9340000000.9441.1231.27812.4111.06233.4111.51175.0421.4032.3052.0281.45816.4211.0740.7532.0061.431.33319.9640.4870.31524.37414.1660.23526.0210.1882.032.03
Cost of Revenue 17.13815.16514.64412.40713.68213.87315.13614.38515.69215.12320.12415.11813.7113.32915.95115.51812.80915.20914.66211.47812.711.59212.12711.54610.53310.06910.1558.1956.8387.4547.067.6965.6465.3725.7034.1564.4542.7365.0953.8273.5973.597
Gross Profit -16.451-15.1650.157-12.407-13.682-13.873-15.135-10.451-15.692-15.123-20.124-15.118-13.71-13.329-15.007-14.395-11.531-2.798-13.621.933-11.18963.45-10.724-9.241-8.505-8.6116.266-7.121-6.085-5.448-5.63-6.36314.318-4.885-5.38820.2189.712-2.50120.926-3.639-1.567-1.567
Gross Profit Ratio -23.94600.011000-15,135-2.657000000-15.897-12.818-9.023-0.225-12.8060.656-7.4050.846-7.644-4.009-4.194-5.9060.382-6.63-8.081-2.716-3.937-4.7730.717-10.031-17.1050.8290.686-10.6430.804-19.356-0.772-0.772
Reseach & Development Expenses 17.13815.16514.64412.40713.68213.87315.13614.38515.69215.12320.12415.11813.7113.32915.95115.51812.80915.20914.66211.47812.711.59212.12711.54610.53310.06910.1558.1956.8387.4547.067.6965.6465.3725.7034.1564.4542.7365.0953.8273.5973.597
General & Administrative Expenses 4.5514.971-0.6763.4653.6814.106-2.2463.2744.3744.166-4.1145.425.2354.338-2.4674.8924.1564.504-1.4143.9563.5853.294-1.1392.933.0652.711-0.7792.5192.1682.3860.2641.7131.8510.493-0.4590.890.5560.431.1190.8280.7450.745
Selling & Marketing Expenses 000000000000000000000000000000000000000000
SG&A 4.5514.971-0.6763.4653.6814.106-2.2463.2744.3744.166-4.1145.425.2354.338-2.4674.8924.1564.504-1.4143.9563.5853.294-1.1392.933.0652.711-0.7792.5192.1682.3860.2641.7131.8510.493-0.4590.890.5560.431.1190.8280.7450.745
Other Expenses -17.1790000-0.4085.808-0.262-0.207-0.4596.777-0.255-0.256-0.4166.925-0.482006.63700.0364.5054.9030003.8570003.168000.4061.37700.4120.3440000
Operating Expenses 21.64820.06818.34215.46617.04617.57118.69817.39719.85918.8322.78720.28318.68917.25120.40919.92816.96519.71319.88515.43416.28514.88615.89114.47613.59812.7813.23310.7149.0069.8410.4929.4097.4976.2716.6215.0465.4223.511.1180.820.7440.744
Operating Income -20.961-20.068-3.541-15.466-17.046-17.571-18.697-13.463-19.859-18.83-22.787-20.283-18.689-17.251-19.465-18.805-15.687-7.302-18.82317.977-14.77460.156-14.488-12.171-11.57-11.3223.188-9.64-8.253-7.834-9.062-8.07612.467-5.784-6.30619.3288.744-3.27519.807-4.467-2.312-2.312
Operating Income Ratio -30.5110-0.239000-18,697-3.422000000-20.62-16.745-12.275-0.588-17.7240.538-9.7780.802-10.326-5.28-5.705-7.7650.194-8.976-10.96-3.905-6.337-6.0590.624-11.877-20.0190.7930.617-13.9360.761-23.761-1.139-1.139
Total Other Income Expenses Net -2.5041.613-1.2020.067-0.0160.061-0.05-0.0490.219-0.014-0.3740.122-0.1780.543-0.035-0.189-0.051-0.387-2.0130.2360.0364.505-0.189-1.3450.427-0.2920.7070.858-4.074-1.621-0.0360.0350.4770.0010.7260.817-0.1750.2970.0050.0180.0020.002
Income Before Tax -22.76-17.862-4.743-15.14-16.83-17.51-18.747-13.512-19.64-18.844-21.273-15.918-19.069-16.734-19.5-18.994-15.738-7.689-19.44618.213-16.89963.574-14.677-13.516-11.143-11.6144.164-8.793-12.327-9.455-4.767-9.10212.944-6.175-5.58420.0998.588-2.96519.812-4.449-2.31-2.31
Income Before Tax Ratio -33.130-0.32000-18,747-3.435000000-20.657-16.914-12.315-0.62-18.3110.545-11.1840.847-10.461-5.864-5.495-7.9660.254-8.187-16.371-4.713-3.334-6.8280.648-12.68-17.7270.8250.606-12.6170.761-23.665-1.138-1.138
Income Tax Expense 0.0340.0360.0010.0030.0030.0030.0020.0040.0030.0040.0030.1810.2020.026-0.003-0.1460.004-0.3330.2080.3220.5041.0960.043-1.3140.449-0.280.7680.869-40.013-0.7511.0960.4770.3930.7470.87-0.1770.2990000
Net Income -22.76-17.862-4.744-15.143-16.833-17.513-18.749-13.516-19.643-18.848-21.276-15.918-19.069-16.734-19.5-18.994-15.738-7.689-19.44618.213-16.89963.574-14.677-13.516-11.143-11.6144.164-8.793-12.327-9.455-4.767-9.10212.944-6.175-5.58420.0998.588-2.96519.812-4.449-2.31-2.31
Net Income Ratio -33.130-0.321000-18,749-3.436000000-20.657-16.914-12.315-0.62-18.3110.545-11.1840.847-10.461-5.864-5.495-7.9660.254-8.187-16.371-4.713-3.334-6.8280.648-12.68-17.7270.8250.606-12.6170.761-23.665-1.138-1.138
EPS -0.23-0.18-0.055-0.18-0.2-0.21-0.22-0.16-0.23-0.23-0.29-0.22-0.26-0.23-0.27-0.26-0.22-0.11-0.270.25-0.240.94-0.22-0.21-0.19-0.20.073-0.15-0.22-0.17-0.085-0.180.23-0.11-0.10.360.16-0.0540.37-0.1-0.054-0.054
EPS Diluted -0.23-0.18-0.055-0.18-0.2-0.21-0.22-0.16-0.23-0.23-0.29-0.22-0.26-0.23-0.27-0.26-0.22-0.11-0.270.25-0.240.91-0.21-0.21-0.19-0.20.073-0.15-0.22-0.17-0.084-0.180.23-0.11-0.10.360.16-0.0540.37-0.1-0.054-0.054
EBITDA -19.674-18.883-4.162-14.632-16.246-16.792-18.034-12.873-19.284-18.23-20.098-15.222-18.096-16.703-18.951-18.45-15.21-7.159-16.75418.731-16.03560.56-14.179-13.233-10.875-11.4054.405-8.623-12.111-7.722-5.402-7.98213.02-5.72-5.49120.2268.659-2.89519.882-4.392-2.238-2.238
EBITDA Ratio -28.6380-0.281000-18,034-3.272000000-20.075-16.429-11.901-0.577-15.7760.561-10.6120.807-10.106-5.741-5.362-7.8220.268-8.029-16.084-3.849-3.778-5.9880.652-11.745-17.4320.830.611-12.3190.764-23.362-1.102-1.102